Oncosil Medical Ltd (OSL) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.814x

Based on the latest financial reports, Oncosil Medical Ltd (OSL) has a cash flow conversion efficiency ratio of -1.814x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-6.96 Million ≈ $-4.93 Million USD) by net assets (AU$3.84 Million ≈ $2.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Oncosil Medical Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Oncosil Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Oncosil Medical Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Oncosil Medical Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oncosil Medical Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
COSCIENS Biopharma Inc. NASDAQ:CSCI	-0.627x
Vital Energy Inc V:VUX	0.110x
Carver Bancorp Inc NASDAQ:CARV	-0.059x
Airway WAR:AWM	1.059x
Investsmart Group Ltd AU:INV	0.282x
Gema Grahasarana Tbk JK:GEMA	0.016x
Pescanova SA MC:PVA	0.084x
Batero Gold Corp V:BAT	-0.003x

Annual Cash Flow Conversion Efficiency for Oncosil Medical Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Oncosil Medical Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Oncosil Medical Ltd (OSL) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$3.10 Million ≈ $2.20 Million	AU$-12.06 Million ≈ $-8.53 Million	-3.887x	-70.07%
2024-06-30	AU$4.74 Million ≈ $3.35 Million	AU$-10.82 Million ≈ $-7.66 Million	-2.285x	-99.55%
2023-06-30	AU$9.88 Million ≈ $6.99 Million	AU$-11.32 Million ≈ $-8.01 Million	-1.145x	-26.45%
2022-06-30	AU$11.16 Million ≈ $7.90 Million	AU$-10.11 Million ≈ $-7.15 Million	-0.906x	-20.17%
2021-06-30	AU$11.70 Million ≈ $8.28 Million	AU$-8.82 Million ≈ $-6.24 Million	-0.754x	-270.43%
2020-06-30	AU$21.90 Million ≈ $15.50 Million	AU$-4.46 Million ≈ $-3.15 Million	-0.203x	+71.04%
2019-06-30	AU$10.68 Million ≈ $7.55 Million	AU$-7.50 Million ≈ $-5.31 Million	-0.703x	-51.92%
2018-06-30	AU$18.15 Million ≈ $12.85 Million	AU$-8.40 Million ≈ $-5.94 Million	-0.463x	+23.27%
2017-06-30	AU$10.13 Million ≈ $7.17 Million	AU$-6.11 Million ≈ $-4.32 Million	-0.603x	-95.27%
2016-06-30	AU$14.81 Million ≈ $10.48 Million	AU$-4.57 Million ≈ $-3.24 Million	-0.309x	-1155.70%
2015-06-30	AU$6.96 Million ≈ $4.93 Million	AU$-171.16K ≈ $-121.11K	-0.025x	+96.33%
2014-06-30	AU$9.52 Million ≈ $6.73 Million	AU$-6.37 Million ≈ $-4.51 Million	-0.669x	-758.32%
2013-06-30	AU$6.05 Million ≈ $4.28 Million	AU$-471.91K ≈ $-333.90K	-0.078x	+36.67%
2012-06-30	AU$2.48 Million ≈ $1.76 Million	AU$-305.78K ≈ $-216.36K	-0.123x	-13.30%
2011-06-30	AU$2.91 Million ≈ $2.06 Million	AU$-316.67K ≈ $-224.06K	-0.109x	-281.54%
2010-06-30	AU$2.58 Million ≈ $1.82 Million	AU$154.35K ≈ $109.21K	0.060x	+346.60%
2009-06-30	AU$4.28 Million ≈ $3.03 Million	AU$-103.97K ≈ $-73.57K	-0.024x	+95.45%
2008-06-30	AU$4.09 Million ≈ $2.89 Million	AU$-2.18 Million ≈ $-1.54 Million	-0.533x	-85.54%
2007-06-30	AU$4.68 Million ≈ $3.31 Million	AU$-1.35 Million ≈ $-952.00K	-0.288x	-902.55%
2006-06-30	AU$5.46 Million ≈ $3.86 Million	AU$195.51K ≈ $138.34K	0.036x	+278.21%
2005-06-30	AU$899.56K ≈ $636.50K	AU$-18.08K ≈ $-12.80K	-0.020x	--

About Oncosil Medical Ltd

AU:OSL Australia Medical Devices

Market Cap

$8.35 Million

AU$11.81 Million AUD

Market Cap Rank

#27293 Global

#1390 in Australia

Share Price

AU$0.50

Change (1 day)

-2.91%

52-Week Range

AU$0.00 - AU$1.99

All Time High

AU$1.99